366 related articles for article (PubMed ID: 24291273)
1. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.
Bonello L; Laine M; Kipson N; Mancini J; Helal O; Fromonot J; Gariboldi V; Condo J; Thuny F; Frere C; Camoin-Jau L; Paganelli F; Dignat-George F; Guieu R
J Am Coll Cardiol; 2014 Mar; 63(9):872-7. PubMed ID: 24291273
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome.
Torngren K; Ohman J; Salmi H; Larsson J; Erlinge D
Cardiology; 2013; 124(4):252-8. PubMed ID: 23594617
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.
Bonello L; Frere C; Cointe S; Laine M; Mancini J; Thuny F; Kerbaul F; Lemesle G; Paganelli F; Guieu R; Arnaud L; Dignat-George F; Sabatier F
Int J Cardiol; 2015; 187():502-7. PubMed ID: 25846661
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study.
Alexopoulos D; Galati A; Xanthopoulou I; Mavronasiou E; Kassimis G; Theodoropoulos KC; Makris G; Damelou A; Tsigkas G; Hahalis G; Davlouros P
J Am Coll Cardiol; 2012 Jul; 60(3):193-9. PubMed ID: 22789884
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease.
Wang H; Qi J; Li Y; Tang Y; Li C; Li J; Han Y
Br J Clin Pharmacol; 2018 Jan; 84(1):88-96. PubMed ID: 28921624
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor Compared with Clopidogrel Increased Adenosine and Cyclic Adenosine Monophosphate Plasma Concentration in Acute Coronary Syndrome Patients.
Li X; Wang Q; Xue Y; Chen J; Lv Q
Basic Clin Pharmacol Toxicol; 2017 Jun; 120(6):610-614. PubMed ID: 28052578
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromes.
Husted S
Postgrad Med; 2011 Nov; 123(6):79-90. PubMed ID: 22104457
[TBL] [Abstract][Full Text] [Related]
9. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.
Cheng JW
Clin Ther; 2012 Jun; 34(6):1209-20. PubMed ID: 22521881
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy.
Storey RF; Angiolillo DJ; Patil SB; Desai B; Ecob R; Husted S; Emanuelsson H; Cannon CP; Becker RC; Wallentin L
J Am Coll Cardiol; 2010 Oct; 56(18):1456-62. PubMed ID: 20832963
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial.
Levin LÅ; Wallentin L; Bernfort L; Andersson D; Storey RF; Bergström G; Lamm CJ; Janzon M; Kaul P
Value Health; 2013 Jun; 16(4):574-80. PubMed ID: 23796291
[TBL] [Abstract][Full Text] [Related]
13. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial.
Steg PG; Harrington RA; Emanuelsson H; Katus HA; Mahaffey KW; Meier B; Storey RF; Wojdyla DM; Lewis BS; Maurer G; Wallentin L; James SK;
Circulation; 2013 Sep; 128(10):1055-65. PubMed ID: 23900047
[TBL] [Abstract][Full Text] [Related]
14. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor for acute coronary syndromes.
Bansilal S; Bonaca MP; Sabatine MS
Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1473-84. PubMed ID: 24147518
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).
Storey RF; Becker RC; Harrington RA; Husted S; James SK; Cools F; Steg PG; Khurmi NS; Emanuelsson H; Lim ST; Cannon CP; Katus HA; Wallentin L
Am J Cardiol; 2011 Dec; 108(11):1542-6. PubMed ID: 21890085
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor.
Gaglia MA; Lipinski MJ; Lhermusier T; Steinvil A; Kiramijyan S; Pokharel S; Torguson R; Angiolillo DJ; Wallentin L; Storey RF; Waksman R
Am J Cardiol; 2017 Apr; 119(8):1135-1140. PubMed ID: 28202132
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
[TBL] [Abstract][Full Text] [Related]
19. Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes.
Berger JS
Am J Cardiol; 2013 Sep; 112(5):737-45. PubMed ID: 23751937
[TBL] [Abstract][Full Text] [Related]
20. Impact of initial clinical presentation on clopidogrel low response.
Landel JB; Bauters A; Delhaye C; Bonello L; Sudre A; Susen S; Bauters C; Lablanche JM; Lemesle G
Arch Cardiovasc Dis; 2013 Nov; 106(11):593-600. PubMed ID: 24070598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
